BlackRock Institutional Trust’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

BlackRock Institutional Trust’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-693,728	Closed	-$20.9M	–	3982
2016 Q2	$20.9M	Buy	693,728 +622,276	+871%	+$12.6M	﹤0.01%	1818
2016 Q1	$788K	Hold	71,452	–	–	﹤0.01%	3348
2015 Q4	$126K	Buy	71,452 +40,793	+133%	+$69.9K	﹤0.01%	3722
2015 Q3	$51K	Buy	+30,659	New	+$68K	﹤0.01%	3811

BlackRock Institutional Trust's CPXX Position: Q3 2016 in Review

BlackRock Institutional Trust sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 693,728 shares — an estimated $20.9M sold.

BlackRock Institutional Trust first reported a position in CPXX in Q3 2015 and held it in 4 quarters. The position peaked at $20.9M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

BlackRock Institutional Trust reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
BlackRock Institutional Trust sold 693,728 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $20.9M.
BlackRock Institutional Trust first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q3 2015 and held it in 4 quarters.
BlackRock Institutional Trust's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $20.9M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on BlackRock Institutional Trust's 13F filing for Q3 2016, filed 8 Nov 2016.